Atmosr
Develops small-molecule treatments for patients with severe neurological and rare diseases
Highlights
- New on EvolcAdded 2026-11-11
About Atmosr
AtmosR develops small-molecule HSP90 inhibitors designed to cross the blood-brain barrier and address protein aggregation in neurological disorders. Its programs include CCHS, Kennedy disease and Huntington disease.
The company works with patient communities, academic experts and private laboratories on drug development. It was founded in 2019 and is headquartered in Fuveau, France; it also presents a laboratory in Paris.
Product: Small-molecule HSP90 inhibitor drug candidates for neurological disorders.
Jobs at Atmosr
More biotech & pharma companies
Azur Genetique
Forensic DNA identification lab in Nice serving French courts, the Gendarmerie and the Police NationaleB Cell Design
Human Fc monoclonal antibodies and development services for diagnostic and biopharmaceutical companiesNew on Evolcbanyuls-bacterial-culture-collection.fr
Culture collection of over 3,700 environmental bacterial strains, held at the Banyuls Observatory in France for research useNew on EvolcBenta
Contract manufacturer and generic drug producer near Lyon, supplying pharma partners and French pharmacies and hospitalsNew on EvolcBforcure
Point-of-need microorganism analysis instruments and PCR design software for medical, food, water and agriculture labsNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Backend
- PHPHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerx-powered-by
- Response headerx-powered-by
- Response headerx-powered-by
Content management
- ElementorHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
- WordPressHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Forms
- Google reCAPTCHAHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Frontend frameworks
- jQueryHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Hosting
- ApacheHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerserver
- Response headerserver
- Response headerserver
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.